Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q3 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.